scholarly journals 1209: LONG-TERM HEALTH-RELATED QUALITY OF LIFE AFTER VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION

2021 ◽  
Vol 50 (1) ◽  
pp. 604-604
Author(s):  
Obaid Ashraf ◽  
Subbarao Elapavaluru ◽  
Michael Collins ◽  
Manreet Kawar ◽  
Srinivas Murali
Heart & Lung ◽  
2019 ◽  
Vol 48 (6) ◽  
pp. 538-552 ◽  
Author(s):  
Krista A. Knudson ◽  
Carolina M. Gustafson ◽  
Lois S. Sadler ◽  
Robin Whittemore ◽  
Nancy S. Redeker ◽  
...  

2019 ◽  
Vol 130 (4) ◽  
pp. 572-580 ◽  
Author(s):  
Giacomo Grasselli ◽  
Vittorio Scaravilli ◽  
Daniela Tubiolo ◽  
Riccarda Russo ◽  
Francesco Crimella ◽  
...  

Abstract Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New Background Survivors of acute respiratory distress syndrome (ARDS) have long-term impairment of pulmonary function and health-related quality of life, but little is known of outcomes of ARDS survivors treated with extracorporeal membrane oxygenation. The aim of this study was to compare long-term outcomes of ARDS patients treated with or without extracorporeal membrane oxygenation. Methods A prospective, observational study of adults with ARDS (January 2013 to December 2015) was conducted at a single center. One year after discharge, survivors underwent pulmonary function tests, computed tomography of the chest, and health-related quality-of-life questionnaires. Results Eighty-four patients (34 extracorporeal membrane oxygenation, 50 non–extracorporeal membrane oxygenation) were studied; both groups had similar characteristics at baseline, but comorbidity was more common in non–extracorporeal membrane oxygenation (23 of 50 vs. 4 of 34, 46% vs. 12%, P < 0.001), and severity of hypoxemia was greater in extracorporeal membrane oxygenation (median Pao2/Fio2 72 [interquartile range, 50 to 103] vs. 114 [87 to 133] mm Hg, P < 0.001) and respiratory compliance worse. At 1 yr, survival was similar (22/33 vs. 28/47, 66% vs. 59%; P = 0.52), and pulmonary function and computed tomography were almost normal in both groups. Non–extracorporeal membrane oxygenation patients had lower health-related quality-of-life scores and higher rates of posttraumatic stress disorder. Conclusions Despite more severe respiratory failure at admission, 1-yr survival of extracorporeal membrane oxygenation patients was not different from that of non–extracorporeal membrane oxygenation patients; each group had almost full recovery of lung function, but non–extracorporeal membrane oxygenation patients had greater impairment of health-related quality of life.


2019 ◽  
Vol 6 (4) ◽  
pp. 701-710 ◽  
Author(s):  
Marte Christine Ørbo ◽  
Sidsel Fredheim Karlsen ◽  
Ellinor Phillips Pedersen ◽  
Stig Eggen Hermansen ◽  
Per Bjørnerud Rønning ◽  
...  

2019 ◽  
Vol 28 (7) ◽  
pp. 1090-1098 ◽  
Author(s):  
Mark A. Roll ◽  
Suzanne Kuys ◽  
James R. Walsh ◽  
Oystein Tronstad ◽  
Marc D. Ziegenfuss ◽  
...  

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Mads G. Jørgensen ◽  
Navid M. Toyserkani ◽  
Frederik G. Hansen ◽  
Anette Bygum ◽  
Jens A. Sørensen

AbstractThe impact of breast cancer-related lymphedema (BCRL) on long-term quality of life is unknown. The aim of this study was to investigate the impact of BCRL on health-related quality of life (HRQoL) up to 10 years after breast cancer treatment. This regional population-based study enrolled patients treated for breast cancer with axillary lymph node dissection between January 1st 2007 and December 31th 2017. Follow up and assessments of the included patients were conducted between January 2019 and May 2020. The study outcome was HRQoL, evaluated with the Lymphedema Functioning, Disability and Health Questionnaire, the Disabilities of the Arm, Shoulder and Hand Questionnaire and the Short Form (36) Health Survey Questionnaire. Multivariate linear logistic regression models adjusted for confounders provided mean score differences (MDs) with 95% confidence intervals in each HRQoL scale and item. This study enrolled 244 patients with BCRL and 823 patients without BCRL. Patients with BCRL had significantly poorer HRQoL than patients without BCRL in 16 out of 18 HRQoL subscales, for example, in physical function (MDs 27, 95%CI: 24; 30), mental health (MDs 24, 95%CI: 21; 27) and social role functioning (MDs 20, 95%CI: 17; 23). Age, BMI, BCRL severity, hand and dominant arm affection had only minor impact on HRQoL (MDs < 5), suggesting a high degree of inter-individual variation in coping with lymphedema. This study showed that BCRL is associated with long-term impairments in HRQoL, especially affecting the physical and psychosocial domains. Surprisingly, BCRL diagnosis rather than clinical severity drove the largest impairments in HRQoL.


Sign in / Sign up

Export Citation Format

Share Document